Aadi Bioscience (AADI) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free AADI Stock Alerts $2.12 +0.10 (+4.95%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNeil Desai Sells 40,000 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) Stockamericanbankingnews.com - May 3 at 5:18 AMAadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells 40,000 Shares of Stockinsidertrades.com - May 2 at 6:37 AMAadi Bioscience to Report First Quarter 2024 Results and Corporate Updateprnewswire.com - May 1 at 8:01 AMBiodexa gains license for polyposis asset as stock more than doublesfinance.yahoo.com - April 29 at 3:00 PMShort Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Expands By 16.6%americanbankingnews.com - April 29 at 3:04 AMCongress releases candidate list for three Lok Sabha, 11 Assembly seats in Andhra Pradeshmsn.com - April 26 at 2:05 AMAadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meetingfinance.yahoo.com - April 9 at 8:51 AMAadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meetingprnewswire.com - April 9 at 8:00 AMAadi Bioscience, Inc. (NASDAQ:AADI) Chairman Neil Desai Sells 17,772 Sharesinsidertrades.com - April 4 at 6:52 AMAadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)prnewswire.com - March 17 at 8:00 AMEarnings call: Aadi Bioscience sees 60% growth in FYARRO salesuk.investing.com - March 16 at 11:55 PMAADI Apr 2024 10.000 callfinance.yahoo.com - March 16 at 8:01 AMAADI Oct 2024 2.500 putfinance.yahoo.com - March 16 at 12:02 AMAADI Jul 2024 2.500 putfinance.yahoo.com - March 16 at 12:02 AMAadi Bioscience, Inc. (AADI) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 15 at 8:57 PMAadi Bioscience, Inc. (NASDAQ:AADI) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 15 at 11:13 AMAadi Bioscience Earnings Previewbenzinga.com - March 14 at 4:06 PMAadi Bioscience Full Year 2023 Earnings: US$2.44 loss per share (vs US$2.69 loss in FY 2022)finance.yahoo.com - March 14 at 7:32 AMQ4 2023 Aadi Bioscience Inc Earnings Callfinance.yahoo.com - March 14 at 12:09 AMTD Cowen Keeps Their Buy Rating on Aadi Bioscience (AADI)markets.businessinsider.com - March 13 at 7:09 PMAadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Updateprnewswire.com - March 13 at 8:00 AMHere's what Wall Street expects from Aadi Bioscience's earnings reportmarkets.businessinsider.com - March 12 at 1:44 PMAadi Bioscience (AADI) Set to Announce Quarterly Earnings on Wednesdaymarketbeat.com - March 7 at 1:08 PMAadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Updatefinance.yahoo.com - March 6 at 4:51 PMAadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024prnewswire.com - March 5 at 4:30 PMAadi reports durable response in PEComa treatment studyinvesting.com - March 2 at 11:34 PMStocks to Watch: BioVie, Aadi Biosciencemarketwatch.com - March 1 at 7:15 PMAadi Bioscience Shares Rise After Data Supports Fyarro as Treatment for Malignant PEComamarketwatch.com - March 1 at 6:42 PMAadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComaprnewswire.com - March 1 at 4:08 PMAadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conferencefinance.yahoo.com - February 26 at 4:16 PMAadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conferenceprnewswire.com - February 26 at 4:05 PMEvelo Biosciences Inc (EVLO)investing.com - February 24 at 6:49 AMAadi Bioscience Stock (NASDAQ:AADI) Insider Tradesbenzinga.com - February 23 at 10:47 PMAadi Bioscience files for $150M mixed shelfmsn.com - February 12 at 5:52 PMAadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposiumfinance.yahoo.com - January 26 at 8:34 PMAadi Bioscience Inc AADImorningstar.com - January 23 at 9:52 PMAadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposiumfinance.yahoo.com - January 19 at 5:01 PMEOSE, SPI and VAPO among pre-market losersseekingalpha.com - December 18 at 9:14 AMAadi Bioscience: New Data Drives A Beaten Company Down, Not Really Justifiedseekingalpha.com - December 17 at 8:25 AMHC Wainwright & Co. Downgrades Aadi Bioscience (AADI)msn.com - December 16 at 1:56 PMAnalysts Have Conflicting Sentiments on These Healthcare Companies: PolyPid (PYPD), Aadi Bioscience (AADI) and Cullinan Management (CGEM)markets.businessinsider.com - December 15 at 8:23 PMCancer Player Aadi Bioscience Downgraded: Analyst Highlights 'Worse Than Expected' Response Ratesmarkets.businessinsider.com - December 15 at 3:22 PMWhy Is Anti-Cancer Focused Aadi Bioscience Stock Trading Lower Today?msn.com - December 15 at 1:04 PMPiper Sandler Trims Aadi Bioscience (NASDAQ:AADI) Target Price to $5.00marketbeat.com - December 15 at 12:29 PMWhy Is Aadi Bioscience (AADI) Stock Down 56% Today?msn.com - December 15 at 9:29 AMAadi Bioscience stock plunges 57% on study data for anti-tumor drugmsn.com - December 14 at 5:39 PMAadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterationsfinance.yahoo.com - December 14 at 5:39 PMAadi Bioscience, Inc. (NASDAQ:AADI) is definitely on the radar of institutional investors who own 39% of the companyfinance.yahoo.com - December 13 at 7:22 AMHow Much Upside is Left in Aadi Bioscience, Inc. (AADI)? Wall Street Analysts Think 509.98%finance.yahoo.com - November 29 at 3:28 PMAadi Bioscience Stock (NASDAQ:AADI), Analyst Ratings, Price Targets, Predictionsbenzinga.com - November 25 at 9:30 AM Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Email Address The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about... Click here to see Louis' new video for yourself. AADI Media Mentions By Week AADI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AADI News Sentiment▼0.480.42▲Average Medical News Sentiment AADI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AADI Articles This Week▼62▲AADI Articles Average Week Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RMTI News Today IMRX News Today BOLT News Today CLNN News Today JAN News Today APLM News Today OCUP News Today MRKR News Today NXTC News Today XLO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AADI) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
